Track the Nanologica AB (publ) share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Nanologica AB (publ) has published 4 public disclosures. Market capitalisation: €150.2m. The latest transaction was disclosed on 21 April 2026 (Purchase). Among the most active insiders: Thomas Eldered. The full history is openly available.
4
Insider Decl.
n/a
Thresholds
€920,347
3 ops.
Buy Volume
n/a
n/a
Sell Volume
36Σ signal
Buys €920,347n/a Sells
Fundamental score
Ranked 22,215 of 29,062 companies
33.4
score / 100
Value
7
Quality
59
FCF yld-28%
Earn yld-35%
EV/EBITDA·
ROE30%
Gross mgn20%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
293,815 shares@ €0.08840.016% mcap100.0% of flowAktieISINISIN SE0005454873FI:A003Q717-1
4 of 4 declarations
Acerca de Nanologica AB (publ)
Nanologica AB (publ) es una empresa sueca enfocada en el desarrollo de soluciones innovadoras para la administración de fármacos. Cotiza en el mercado XSTO.